In recent years, pharmaceutical companies have paid increasing attention to the impact of pharmaceutical excipients on drug quality and safety. In the pharmaceutical industry, pharmaceutical excipients, previously known as "minor supporting roles," have changed and started to move to the forefront.

  The new GMP will encourage pharmaceutical excipient companies to require higher standards, such as pharmaceutical GMP requirements for pharmaceutical excipient companies, and most companies will go to the production site of the pharmaceutical excipient company for inspection. This phenomenon will have a significant impact on the pharmaceutical excipient industry.

  Relevant institutions predict that during the "Twelfth Five-Year Plan" period, the domestic pharmaceutical excipient market will grow at an annual rate of about 20%. By 2015, the market size may reach 40 billion yuan. Competition in the pharmaceutical excipient market will become more intense.

  Currently, the industry attaches great importance to industrial policies and hopes that the government will issue more regulations and documents on the production and management of pharmaceutical excipients to accelerate the construction of its system and standards, shorten the approval period, and improve efficiency.

  In the development process of the pharmaceutical excipient industry, pharmaceutical companies urgently need to recognize the importance of pharmaceutical excipient quality. More and more people believe that pharmaceutical excipients and raw materials have the same requirements. In the new GMP, many places combine raw materials and pharmaceutical excipients as raw materials, and there is no difference in requirements; in the preparation process, pharmaceutical excipients should be changed, confirmation or verification must be carried out, and approval from drug regulatory authorities must be obtained if necessary; pharmaceutical manufacturers should be responsible for the quality inspection, quality status, and sample retention of the pharmaceutical excipients used. The above is the main content of the new GMP,

  In the next few years, the characteristics of customized production will become increasingly prominent in the pharmaceutical excipient industry. In this case, pharmaceutical excipient products with good product quality and high safety are increasingly becoming the mainstream of the pharmaceutical excipient market. In the future, pharmaceutical excipient manufacturers focusing on product quality will develop better.